Remus Pharmaceuticals Limited (NSE:REMUS)
601.00
-75.90 (-11.21%)
Mar 27, 2026, 3:29 PM IST
-44.67% (1Y)
| Market Cap | 7.89B -37.5% |
| Revenue (ttm) | 7.48B +63.8% |
| Net Income | 335.10M +12.1% |
| EPS | 27.37 +7.9% |
| Shares Out | 11.66M |
| PE Ratio | 24.73 |
| Forward PE | n/a |
| Dividend | 1.00 (0.15%) |
| Ex-Dividend Date | Nov 14, 2025 |
| Volume | 12,900 |
| Average Volume | 4,440 |
| Open | 628.00 |
| Previous Close | 676.90 |
| Day's Range | 601.00 - 636.00 |
| 52-Week Range | 580.00 - 1,145.00 |
| Beta | -0.00 |
| RSI | 54.68 |
| Earnings Date | May 15, 2026 |